Trademarkia Logo

Canada

C$
MADRIGAL PHARMACEUTICALS
ADVERTISED

on 16 Apr 2025

Last Applicant/ Owned by

Madrigal Pharmaceuticals, Inc.

200 Barr Harbor Drive, Suite 200West Conshohocken PA 19428

US

Serial Number

2300566 filed on 30th Oct 2023

MADRIGAL PHARMACEUTICALS

Trademark usage description

pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (nash) with liver fibrosis. licensing services, namely, Read More

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis.


Classification kind code

12

Class [045]
Licensing services, namely, licensing of pharmaceutical intellectual property rights to third parties.


Classification kind code

12

Mark Details


Serial Number

2300566

Mark Type

Trademark

Legal History


Action TakenStatus
Submitted for opposition 42
on 16th Apr 2025
Advertised
Submitted for opposition 27
on 19th Mar 2025
Approval Notice Sent
Submitted for opposition 26
on 19th Mar 2025
Approved
Submitted for opposition 22
on 11th Mar 2025
Search Recorded
Submitted for opposition 256
on 21st Oct 2024
Notification of Possible Opposition Sent
Submitted for opposition 257
on 21st Dec 2023
Designation Notification - Madrid Protocol
Submitted for opposition 1
on 20th Dec 2023
Created
Submitted for opposition 31
on 20th Dec 2023
Formalized
Submitted for opposition 228
on 30th Oct 2023
International Registration
Submitted for opposition 30
on 30th Oct 2023
Filed